House Publications
The Debates are the report—transcribed, edited, and corrected—of what is said in the House. The Journals are the official record of the decisions and other transactions of the House. The Order Paper and Notice Paper contains the listing of all items that may be brought forward on a particular sitting day, and notices for upcoming items.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
|
|
|
Notice PaperNo. 139 Tuesday, June 12, 2012 10:00 a.m. |
|
|
|
|
Introduction of Government Bills |
|
Introduction of Private Members' Bills |
|
| June 11, 2012 — Mr. Garrison (Esquimalt—Juan de Fuca) — Bill entitled “An Act to amend the Civil Marriage Act (divorce and corollary relief)”. |
Notices of Motions (Routine Proceedings) |
|
Questions |
|
| Q-7292 — June 11, 2012 — Ms. Duncan (Etobicoke North) — With respect to the regulatory requirements for off-label use of a medical device and the special access program: (a) what are the federal regulations that control off-label use of a medical device already approved in Canada; (b) when a device such as a "stent" is proposed to be used by a licensed Canadian surgeon or interventional radiologist for the treatment of a medical condition not originally approved by the Medical Devices Bureau, (i) is there a requirement for a separate set of clinical trials or does such use fall under provincial jurisdiction and their practice of medicine guidelines, (ii) and if off-label use falls under provincial jurisdiction, why did the federal government intervene regarding the new procedure for chronic cerebrospinal venous insufficiency (CCSVI); (c) what are the regulatory requirements for the special access program that allows practitioners to request access to drugs or devices that are not currently approved for use in Canada for patients with serious or life threatening conditions, (i) why did the procedure for chronic CCSVI fail to meet the specified requirements on a compassionate or emergency basis when conventional therapies have failed, are unsuitable, or are unavailable, (ii) how did kidney denervation meet the specified requirements; (d) how many CCSVI procedures worldwide have been performed to date, (i) how many positive and negative peer-reviewed CCSVI studies have been published to date, (ii) how many Canadians are estimated to have had the procedure for CCSVI since January 2010, and how many of them have been followed to date, (iii) how many phase II and phase III clinical trials for CCSVI are currently underway internationally, (iv) in light of the safety findings reported on 1375 patients studied in eight recently published clinical trials on CCSVI, why is Canada beginning with a phase I study; and (e) how many procedures worldwide have been performed for kidney denervation, (i) how many positive and negative peer reviewed studies have been published to date, (ii) had the procedure been assessed through a double-blind trial with a placebo group when the procedure was approved in Canada, (iii) how many safety studies have been published to date, and what is the complication rate, (iv) what phase clinical trials are currently underway internationally, (v) will Canada be undertaking phased clinical trials? |
| Q-7302 — June 11, 2012 — Mr. Thibeault (Sudbury) — With regard to Health Canada's Consumer Product Safety Directorate, since 2005-2006, broken down by fiscal year: (a) how many product safety tests have been conducted; (b) how many product safety tests have resulted in consumer product recalls; (c) how many field inspections have been conducted; (d) how many field inspections have resulted in consumer product recalls; (e) how may product safety tests have resulted in fines; (f) how many inspections have resulted in fines; (g) what is the total monetary value of each fine levied; (h) what is the value of each product seizure which resulted from product safety tests; (i) what is the value of each product seizure which resulted from field inspections; (j) what is the average number of inspections conducted per inspector; and (k) what is the ratio of physical inspections to administrative inspections? |
Notices of Motions for the Production of Papers |
|
Business of Supply |
|
Government Business |
|
Private Members' Notices of Motions |
|
Private Members' Business |
| C-293 — April 30, 2012 — Ms. James (Scarborough Centre) — Consideration at report stage of Bill C-293, An Act to amend the Corrections and Conditional Release Act (vexatious complainants), as reported by the Standing Committee on Public Safety and National Security with an amendment. |
| Pursuant to Standing Order 86(3), jointly seconded by: |
| Mrs. Smith (Kildonan—St. Paul) — October 18, 2011 |
| Committee Report — presented on Monday, April 30, 2012, Sessional Paper No. 8510-411-86. |
| Report and third reading stages — limited to 2 sitting days, pursuant to Standing Order 98(2). |
| Motion for third reading — may be made in the same sitting, pursuant to Standing Order 98(2). |
|
|
|
| 2 Response requested within 45 days |
|